Luminex Return on Equity

Luminex (LMNX) currently reports a ROE of 4.74%. That is below the Healthcare sector average of 22.01%. Use the charts on this page to explore Luminex's ROE history and peer comparisons.

Luminex's ROE of 4.74% is lower than the Healthcare sector average of 22.01%. That is roughly 78.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Luminex's current 4.74% should be judged against Healthcare norms (sector average: 22.01%) and against LMNX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 4.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Luminex, and consider following LMNX for alerts when major investors trade the stock.

Luminex is classified in the Healthcare sector. On ROE, it currently shows 4.74% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LMNX with unrelated industries.